Loading…
MRI-Demonstrable Regression of a Pituitary Mass in a Case of Primary Hypothyroidism after a Week of Acute Thyroid Hormone Therapy
Although magnetic resonance imaging (MRI) characteristics of pituitary gland hyperplasia in primary hypothyroidism have been previously described, the time span necessary for the regression of the hyperplasia in response to acute thyroid hormone (TH) therapy has not been defined. A 26-yr-old woman u...
Saved in:
Published in: | The journal of clinical endocrinology and metabolism 1997-03, Vol.82 (3), p.808-811 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Although magnetic resonance imaging (MRI) characteristics of pituitary
gland hyperplasia in primary hypothyroidism have been previously
described, the time span necessary for the regression of the
hyperplasia in response to acute thyroid hormone (TH) therapy has not
been defined.
A 26-yr-old woman underwent 131I ablation 11 yr before
admission. Intermittent poor compliance to levothyroxine (LT4) therapy
led to inappropriately high serum thyroid-stimulating hormone (TSH) for
her triiodothyronine (T3) and thyroxine (T4) levels. The patient was
investigated to rule out TSH-secreting pituitary adenoma or resistance
to TH. On admission, the patient’s clinical features and thyroid
function tests, as well as thyrotropin-releasing hormone (TRH) and
acute T3 suppression tests, were in favor of profound primary
hypothyroidism. MRI revealed symmetrical enlargement of the pituitary
gland with distinct morphological characteristics of a macroadenoma.
The patient began high-dose TH therapy and was rescannned six days
later. The follow-up scan revealed a dramatic shrinkage of the
pituitary gland. Four weeks later, serum T4 and TSH were within the
normal range, and repeat MRI scan of the pituitary at that time showed
a normal gland.
This case is the first to document dramatic shrinkage of pituitary
hyperplasia in long-standing primary hypothyroidism within one week of
acute TH therapy. MRI alone is unable to reliably differentiate between
a TSH-secreting pituitary adenoma and hypothyroidism-induced pituitary
hyperplasia. Dynamic endocrine testing as well as repeat pituitary MRI
after a brief TH trial may provide a firm diagnosis in similar cases. |
---|---|
ISSN: | 0021-972X 1945-7197 |
DOI: | 10.1210/jcem.82.3.3796 |